Serhat Ünal
-
- Antibiotic Use and Resistance 27
- Infectious Diseases top 0.5%
- Antimicrobial Resistance in Staphylococcus 34
- SARS-CoV-2 and COVID-19 Research 23
- COVID-19 Clinical Research Studies 21
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 26
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing 28
-
- Pneumonia and Respiratory Infections 20
-
- Streptococcal Infections and Treatments 18
- Co-authors
- Adi̇l Deni̇zli̇Serap Şimşek YavuzÖmrüm UzunYeşeren SaylanMurat AkovaHalis AkalınDeniz GürDuygu Yazgan Aksoy
- Journals
- International Journal of Antimicrobial Agents (17 papers)Vaccines (7 papers)Clinical Microbiology and Infection (6 papers)
- Partner nations
- TürkiyeUnited StatesUnited Kingdom
In The Last Decade
Serhat Ünal
231 papers receiving 4.3k citations
Peers
Comparison fields: 5 of 168
- Applied Microbiology and Biotechnology 296
- Infectious Diseases 1.7k
- Molecular Medicine 437
- Clinical Biochemistry 532
- Critical Care and Intensive Care Medicine 220
Countries citing papers authored by Serhat Ünal
This map shows the geographic impact of Serhat Ünal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serhat Ünal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serhat Ünal more than expected).
Fields of papers citing papers by Serhat Ünal
This network shows the impact of papers produced by Serhat Ünal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serhat Ünal. The network helps show where Serhat Ünal may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Serhat Ünal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 2 | |
| 9 | 2022 | 26 | |
| 10 | 2022 | 0 | |
| 11 | 2020 | 123 | |
| 12 | 2020 | 7 | |
| 13 | Novel coronavirus (SARS-CoV-2) pandemic: Overview and current status | 2020 | 4 |
| 14 | 2020 | 240 | |
| 15 | 2019 | 2 | |
| 16 | 2018 | 20 | |
| 17 | CDC 2013 Urinary Tract Infections with New Diagnostic Criteria | 2014 | 1 |
| 18 | [Epidemiological and molecular characteristics of hospital-acquired methicillin-resistant Staphylococcus aureus strains isolated in Hacettepe University Adult Hospital in 2004-2005]. | 2010 | 13 |
| 19 | 2009 | 4 | |
| 20 | [In vitro susceptibility of respiratory isolates of Streptococcus pneumoniae and Streptococcus pyogenes to telithromycin and 11 other antimicrobial agents: Turkish results of e-BASKETT-II surveillance study]. | 2007 | 5 |
About Serhat Ünal
Serhat Ünal is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases, Molecular Medicine, Clinical Biochemistry and Microbiology, having authored 249 papers that have together received 4.5k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (34 papers), Bacterial Identification and Susceptibility Testing (28 papers), Antibiotic Use and Resistance (27 papers), Antibiotic Resistance in Bacteria (26 papers), SARS-CoV-2 and COVID-19 Research (23 papers), COVID-19 Clinical Research Studies (21 papers), Pneumonia and Respiratory Infections (20 papers) and Streptococcal Infections and Treatments (18 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (296 citations), Infectious Diseases (1.7k citations), Molecular Medicine (437 citations), Clinical Biochemistry (532 citations) and Critical Care and Intensive Care Medicine (220 citations). Serhat Ünal has collaborated with scholars based in Türkiye, United States and United Kingdom. Frequent co-authors include Adi̇l Deni̇zli̇, Serap Şimşek Yavuz, Ömrüm Uzun, Yeşeren Saylan, Murat Akova, Halis Akalın, Deniz Gür, Duygu Yazgan Aksoy, Lokman Uzun and Özgecan Erdem. Their work appears in journals such as International Journal of Antimicrobial Agents, Vaccines, Clinical Microbiology and Infection, Antimicrobial Agents and Chemotherapy and Journal of Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.